Peter M. Voorhees - Comprehensive Cancer Center|Department of Medicine|Division of Hematology|Department of Pharmacology|University of North Carolina at Chapel Hill

基本信息

浏览量：170

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 238 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Acquired Immunity in Patients with Multiple Myeloma Undergoing Maintenance Therapy Post-Autologous Hematopoietic Cell Transplantation

Dragos C. Plesca,David M Foureau,James T. Symanowski,Lawrence Druhan,Hailey Hill,Allison Karabinos, Jessica McElwee, Grace Elsey,Allison Morse,Allene Cook, Meagan Reinfried, Alexandra Wolff,

Transplantation and Cellular Therapyno. 2 (2024): S455

引用0浏览0引用

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

Natalie S Callander, Rebecca Silbermann,Jonathan L Kaufman, Kelly N Godby, Jacob Laubach,Timothy M Schmidt, Douglas W Sborov,Eva Medvedova, Brandi Reeves,Binod Dhakal, Cesar Rodriguez,Saurabh Chhabra,

Blood cancer journalno. 1 (2024): 69-69

引用0浏览0WOSNATURE引用

Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)

Hamid Ehsan,Myra Robinson,Peter M. Voorhees,Kristen Cassetta, Shanice Borden,Shebli Atrash,Manisha Bhutani, Cindy Varga,Mauricio Pineda-Roman,Reed Friend,Barry A. Paul

Lifeno. 3 (2024): 384

引用0浏览0引用

Idecabtagene Vicleucel (ide-cel) Chimeric Antigen Receptor T-Cell for Plasma Cell Leukemia (PCL): A Multicenter Experience

Gliceida Maria Galarza Fortuna,Surbhi Sidana, Vanna Hovanky,Jack Khouri,Danai Dima,Mehmet H. Kocoglu, Peter Forsberg,Christopher Ferreri, Shebli Atrash,Peter M. Voorhees,Hamza Hashmi,James Davis,

Transplantation and Cellular Therapyno. 2 (2024): S381-S382

引用0浏览0引用

Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)

Hamid Ehsan,Myra Robinson,Peter M Voorhees,Kristen Cassetta, Shanice Borden,Shebli Atrash,Manisha Bhutani,Cindy Varga,Mauricio Pineda-Roman,Reed Friend,Barry A Paul

Life (Basel, Switzerland)no. 3 (2024)

引用0浏览0WOS引用

Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment

Surbhi Sidana, Lauren C Peres,Hamza Hashmi,Hitomi Hosoya,Christopher Ferreri,Jack Khouri,Danai Dima,Shebli Atrash,Peter Voorhees,Gary Simmons,Douglas W Sborov,Nilesh Kalariya,

Haematologicano. 3 (2024): 777-786

引用0浏览0WOS引用

Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide(Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Real World Experience

Cindy Varga,Myra Robinson,Hamid Ehsan,Danielle Roberts, Sara Dicamillo,Vikas Gupta, Shanice Borden,Manisha Bhutani,Barry A. Paul, Shebli Atrash,Christopher Ferreri,Ajay K. Nooka,

Transplantation and Cellular Therapyno. 2 (2024): S377-S378

引用0浏览0引用

Rebecca Silbermann,Jacob Laubach,Jonathan L Kaufman,Douglas W Sborov,Brandi Reeves,Cesar Rodriguez,Ajai Chari,Luciano J Costa, Larry D Anderson,Nitya Nathwani,Nina Shah,Naresh Bumma,

American journal of hematology (2024)

引用0浏览0WOS引用

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

Aimaz Afrough, Hamza Hashmi,Doris K Hansen, Surbhi Sidana,Chul Ahn, Lauren C Peres,Danai Dima, Ciara L Freeman,Omar Castaneda Puglianini, Mehmet H Kocoglu,Shebli Atrash,Peter M Voorhees,

Blood cancer journalno. 1 (2024): 63-63

引用0浏览0WOSNATURE引用

Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

Attaya Suvannasankha,Nizar Bahlis,Suzanne Trudel,Katja Weisel,Christian Koenecke,Albert Oriol,Peter M Voorhees, Aranzazu A Alonso,Natalie S Callander,María-Victoria Mateos, Nishitha Reddy,Shawn Hakim,

Cancer (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn